NeuroPace Inc Sustainability Reports
NeuroPace, Inc. operates as a medical device company that designs, develops, manufactures, and markets brain-responsive neuromodulation systems. Its primary product is the RNS System, an implantable platform designed to monitor brain activity and deliver personalized, real-time treatment at the seizure source for individuals with drug-resistant focal epilepsy.
Sector: Manufacturing
Country: United States
Exchange: Nasdaq
FIGI: BBG001V0SVB1
3 reports from 2022 to 2024
